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INTRODUCTION 
The human @-like globin genes are located on the short arm of chromosome 11 as 
a cluster of five functional genes in the order 5'-~-"y-"y-6-@-3'.' Each globin gene is 
expressed at a sequential stage of development. The e-globin gene is expressed in 
embryonic (yolk sac-derived) erythroid cells, the "y- and "y-globin genes are 
expressed in fetal erythroid cells, and the 6- and P-globin genes are expressed 
primarily in adult erythroid cells.2 In normal adults, the level of fetal hcmoglobin is 
less than 1% of the total hemoglobin.' In a heterozygous non-deletion form of 
hereditary persistence of fetal hemoglobin (HPFH) called "y@' HPFH, the level of 
fetal hemoglobin ranges from 15% to 25% of the total hemoglobin and is composed 
predominantly of 'y chains.' A single base substitution (C - G) was identified 202 
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base-pairs 5' to the cap site (position -202) of the "y-globin gene in an affected 
individual,4 and the presence of this mutation was shown to be closely associatcd with 
the 'y HPFH phenotype in different in,dividuaks 
The generation of transgenic mice has been a useful tool for the study of the 
developmental regulation of human globin genes. When cloned human P-globin and 
y-globin genes containing a limited amount of 5 ' -  and 3'-flanking DNA are intro- 
duced into mouse oocytes and transgcnic lines arc established, these individual genes 
arc rcgulatcd during murine development in a manner similar to that of their murine 
homologs. The human P-globin gene is expressed at the fetal liver stage as well as the 
adult stage of erythropoiesis in a manner analogous to  that of the adult murine pm"J"r- 
globin gene,'-" while the y-globin gene is expressed only at the cmbryonic (yolk sac) 
stage of erythropoiesis in a manner ,analogous to that of the embryonic murinc 
ph'-globin gene.',"'.'' In this paper, we describe expression studies of human globin 
genes in transgenic mice which carry the 40-kilobase (kb) Kpn I fragment of thc 
human p-likc globin gene cluster from an individual with the -202 "yp' HPFH 
mutation. Thc pattcrn of cxprcssion of the human p-, 'y- and Ay-globin genes 
differed from that of their corresponding murine homologs. The Gy-globin gene with 
the -202 HPFH mutation was expressed at  all developmental stages. The normal 
P-globin gene was expressed in adult erythroid cells but was virtually inactive in fetal 
erythroid cells, whereas the normal *y-globin gene was expressed beyond the 
cmbryonic (yolk sac) stage into the fctal stage of development and then became 
inactive in adult erythroid cells. 
MATEFUALS AND METHODS 
Production of Trunsgenic Mice 
The 40-kb K.pn I fragment containing the -202 'y HPFH mutation was purified 
from a cosmid clone4 by agarose gel electrophoresis or sucrose gradient centrifuga- 
tion, followed by centrifugation on a CsCI gradient and dialysis."~" The DNA was 
injected into the pronuclei of (C57BIJ6J x SJL/J)F2 or (C57BL16J X DBA/2J)F2 
fertilized eggs as described Transgenic mice were identified by South- 
ern blot analysis of tail DNA. To generate transgenic embryos and fetuses, heteroq-  
gous transgenic males were mated with normal C57BW6J females. The day that the 
mating plug was observed was designated day 0; pregnant females were sacrificcd on 
the indicated gestation day. Transgenic embryos in each litter were identified by 
dot-blot analysis of DNA prepared from the unused carcass. 
Prepamtion of RNA 
Adult micc were made anemic by three injections (at 12-h intervals) of a solution 
of 0.4% phcnylhydrazine" and sacrificed 5 days after the first injection. Blood was 
collected by retro-orbital bleeding into phosphate-buffered saline containing 10 
Uiml of heparin (PBS-heparin), and cells were recovered by centrifugation. Trans- 
genic embryos were bled from the umbilical cord into PBS-heparin. Blood cells or 
whole tissues were washed in PBS-heparin, and total R N A  was isolated by homoge- 
nization in 4 M guanidinium isothiocyanate followed by centrifugation through 
CSC1.l4 
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RNase Protection Assay 
The labeled antisense R N A  probes used to measure “y and Ay RNA were 
synthesized from the EcoR I-Suu3A fragments of the third exon of the ‘y and Ay 
genes, where four consecutive base differences occur between the ‘y and Ay 
sequences starting at  a point three bases 3‘ to  the termination codon.I5 The labeled 
antisense RNA probe used to measure human P-globin mRNA was synthesized from 
an EcoR I-Pst I fragment spanning the poly(A) addition site. Each probe (1 x lo5 
cpm per assay) was hybridized with 10 pg of total cellular R N A  at 50°C for 18 h in 30 
p,l of a solution containing 40 mM PIPES, pH 6.5,0.4MNaCl, 1 mh4 EDTA, and 80% 
formamide. The R N A  samples were digested with RNase A (40 kg/ml) and RNase 
T l ( 2  &ml) for 30 min at 37°C and then digested with proteinase K (50 p,g/ml) for 15 
min at 37°C. The protected fragments were analyzed by electrophoresis in a 7.5% 
polyacrylamide-7 M urea gel. 
Northern Blot Analysis 
Northern blot analysis was performed using the following 19-mer oligonucleotide 
probes specific for the RNA to be analyzed: 5’-ACAGCAAGAAAGCGAGCTT3‘ 
(human p), 5’-CATCATGGGCAGTGAGCTC-3’ (human “y), 5’-AGAGCAG- 
GAAAGGGGGTIT-3’  (mouse pmdIor), and 5’-GTGTACTGGAATGGAGTTT-3’ 
(mouse p”). These correspond to sequences that start at the second nucleotide of the 
termination codon of these four globin mRNAs. The oligonucleotides were labeled 
with (y-”P]ATP by polynucleotide kinase. Total R N A  from mouse tissues was 
fractionated by formaldehyde gel electrophoresisI6 and transferred to  Genescreen 
Plus membranes (New England Nuclear). Filters were hybridized with the appropri- 
ate oligonucleotide probe (2 x 10’ cpm/ml) a t  42°C in a solution containing 5 x SSC, 
0.5% SDS, 5 x Denhardt’s solution, 50 &sodium phosphate, p H  7.0, and 200 p,giml 
of salmon sperm DNA. Following hybridization, the filters were washed twice for 5 
min at room temperature in a solution containing 2~ SSC and 0.5% SDS, followed 
by a 10-min wash in the same solution at 45°C. 
RESULTS 
Structural Analysis of the Human p-like Globin Gene Cluster in Transgenic Mice 
In order to determine the pattern of integration of the 40-kb fragment, tail-skin 
DNA from individual transgenic mice was analyzed by Southern blotting. The -202 
mutation of the “y-globin gene abolishes a normal Apa I site in the 40-kb @n I 
fragment.’ Therefore, digestion with Apa I allows direct confirmation of the presence 
of the mutation in the insert. As shown in FIGURE 1, fragments of 21.7 kb and 18.2 kb 
were detected in Apa I digests of DNA from four transgenic mouse lines following 
hybridization with a ‘y cDNA probe. Fragments of the expected normal sizes were 
detected in the EcoR I digests. These results demonstrate that all the transgenic 
mice have intact 40-kb inserts that are integrated in tandem arrays. The number of 
copies of the insert per cell in transgenic lines 3, 4, 6, and 10 was estimated to be 
approximately 60,20, 10 and 5,  respectively. 
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FIGURE 1. Structural analysis of the hum,an p-globin gene cluster in transgenic mice. (Upper 
panel) 10 kg of tail DNA was digested with Apa I (left) or EcoR I (right), electrophoresed in a 
0.5% agarose gel, transferred to a nylon membrane, and hybridized to a Gy-globin cDNA probe. 
The number of each transgenic line is indicated above the respective lanes. N, tail DNA from 
non-transgenic control mice. 10 ng each of the microinjected &n I fragment (-202Gy Kpn 1) 
and the 40-kb Kpn I fragment from a Greek.-type Ay HPFH gene containing wild-type Oy-, 6- and 
p-globin genes and the Ay-globin gene with a G + A mutation at position -117 (-117Ay Kpn 
I) were analyzed as positive controls. The locations of DNA molecular weight standards (Hind 
I11 fragments of A DNA) are shown to  the leff of the blot. (Lower panel) The diagram shows the 
40-kb rc$n I fragment aligned in a head-to-tail tandem array and the resulting map of restriction 
sites. TheApa I site is abolished by the -202 C + G mutation, as indicated by the asterisks. 
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Expression of Human Globin Genes in Adult Mice 
Expression of human globin mRNA in adult tissues of two transgenic mouse lines 
(lines 3 and 6) was examined by the RNase protection assay (FIG. 2). Adult mice 
were made anemic by phenylhydrazine treatment. Hemin-induced K562 cells" and 
cytosine arabinoside-induced KMOE cells" were used as positive controls for 
y-globin mRNA and P-globin mRNA, respectively. The specificity of the "y and " y  
probes was determined by the protection patterns observed with Gy and "y control 
RNAs, which were synthesized in vitro using T7 RNA polymerase and the EcoR 
I-Sau3A fragments cloned in the plasmid vector pGEM. The Ay probe was derived 
from the cosmid clone containing the -202 "yP' HPFH 40-kb e n  I fragment, which 
has a deletion of 6 base-pairs 5' to the poly(A) addition signal, AATAAA, of the 
Ay-globin gene. Therefore, a fragment of 134 bases (instead of the expected 161 
bases, as obtained with synthetic "y RNA) is protected when this probe is 
hybridized to Ay-globin mRNA from K562 cells (FIG 2B). The expected fragment of 
161 bases was protected when the "y probe was hybridized to various RNAs (FIG. 
2A). The "y probc yielded a strong positive hybridization signal with blood and 
spleen (but not kidney or liver) RNA from adult anemic transgenic mice, whereas no 
hybridization signal was obtained from any of the mouse tissues with the 
FIGURE 3 shows the results of the RNase protection assays using the human 
p-globin probe. The specific 212-bp fragment protected by the human P-globin probe 
was detected in adult blood and spleen R N A  but not in liver and kidney R N A  from 
either line 3 or line 6 transgenic mice. The protected fragment was not detected in 
spleen RNA from a non-transgenic anemic mouse which was producing large 
amounts of endogenous mouse PmdJor-globin mRNA. These results show that the 
human Gy- and P-globin genes are expressed specifically in erythroid tissues of 
anemic adult transgenic mice. The level of human P-globin mRNA in the line 3 
transgenic mice was approximately 1.0% of that of endogenous mouse P""l"'-globin 
mRNA, and the level of "y-globin mRNA was approximately 20% of that o f  human 
p-globin mRNA. These levels were estimated by Northern blot analysis of the RNA 
using the specific 19-mer oligonucleotide probes listed in MATER~ALS AND METHODS 
(data not shown). 
probe. 
Expression of Human Globin Genes during Mouse Development 
We also analyzed the pattern of expression of the individual human globin genes 
during development in the transgenic mice. RNA samples were isolated from 
erythroid tissues of mouse embryos at day 11 and day 14 of gestation, and these were 
analyzed for the presence of the human globin mRNAs. FIGURE 4 shows the 
expression patterns of "y- and Ay-globin genes during development of line 3 
transgenic mice. The "y-globin mRNA was detected in all of the RNA samples 
tested, including day 11 yolk sac and blood, day 14 liver and blood, and adult blood. 
The "y-globin mRNA was detected, but at significantly lower levels, in embryonic 
(day 11) and fetal (day 14) erythroid tissues. In fetal (day 14) liver RNA, the level of 
"y-globin mRNA was 20-fold lower than that of "y-globin mRNA. In contrast to the 
case of 'y-globin mRNA, "y-globin mRNA was virtually absent in adult blood cell 
RNA. 
FIGURE 5A shows RNase protection assays obtained with RNA samples from 
line 3 transgenic mice using the human P-globin probe. Human P-globin mRNA was 
not detected in R N A  from day 11 blood and yolk sac or from day 14 fetal blood. 
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14 fctal livcr. FIGURE 5B shows the expression patterns of endogenous adult mouse 
(3mnJ"'- and embryonic ph'-globin mRNAs in the same RNA samples, analyzed by 
Northern blot using specific 19-mer oligonucleotide probes. The mouse PmdJ"'-globin 
mRNA was present at approximately equivalent levels in R N A  from fetal livcr, fetal 
FIGURE 3. Analysis of the expression of the human P-globin gene in adult transgenic mice. 
The same RNA samples as in FIGUK~ 2 were analyzed. 10 pg of total RNA was hybridized to 
the Ij-globin antisense RNA probe illustrated below the autoradiograph. The protected RNAs 
were analyzed by 7 M urea-7.5% pnlyacrylamide gel electrophoresis. The autoradiograph was 
exposed for 2 days. 
blood and adult blood, whereas ph'-globin mRNA was detccted only in R N A  from 
day 1 I blood and yolk sac. It is noteworthy that the same fetal liver RNA sample that 
contained high levcls of mouse pm''l''r mRNA yieldcd barcly detectable levels of 
human P-globin mRNA. This same RNA samplc cssentially lacked mouse cmbryonic 
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Ph’ mRNA yet contained significant levels of mRNA from the non-mutated Ay-globin 
genc. 
DISCUSSION 
We have analyzed the expression of human globin genes in transgenic mice 
carrying the 40-kb en I fragment from the human P-like globin gene locus of an 
individual with “$3’ HPFH. In addition to  the normal P-globin human gene, the 
‘7-globin gene which carries the -202 point mutation was expressed in erythroid 
tissues of anemic adult transgenic mice. The expression level of the “y-globin gcne 
was approximately 20% of that of the @globin gcne, which is very similar to  thc level 
FIGURE 4. Analysis of ‘y- and Ay-glohin gene expression during development in transgenic 
mice. Total RNA was isolated from day 11 ( d l l )  yolk sac (y. sac) and blood, day 14 (d14) liver 
and blood, and adult (ad.) blood of line 3 transgenic mice (3) or non-transgenic mice (n). RNase 
protection assays were performed with the antisense ‘y- or Ay-globin RNA probes as descrihed 
in the legend to FIGURE 2. The autoradiograph was exposed for 7 days. 
of H b  F in adult red cells of individuals with “$3‘ HPFH. These results suggest that 
the -202 mutation might contribute to the unexpected expression of the ‘y-globin 
gene in adult transgenic mice. However, it should be noted that enhancer elements in 
the third exon and 3‘ flanking region of the human P-globin are now located 
approximately 10 kb upstream of the “y-globin gene in the head-to-tail tandem 
repeat of the 40-kb insert in the transgenic mice (FIG. 6). The P-globin enhancers are 
capable of activating Ay- and “y-globin promoters in fetal liver or adult erythroid 
tissues of transgenic mice when located 0.2 to 2.5 kb from these promoters.”~”Z2 In 
addition to the -202 mutation, the P-globin enhancers may also contribute to the 
deregulated expression of the human “y-globin gene in adult erythroid cells of the 
transgenic mice. 
It has been previously reported that in transgenic mice, individual cloned human 
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FIGURE 5. Analysis of human P-globin and endogenous mouse PmdJ"'- and ph'-globin gene 
expression during development in transgenic mice. The same RNA samples as in FIGURE 4 
were analyzed. (Panel A) RNase protection assays were performed as described in FIGURE 3 
using the human p-globin antisense RNA probe. (Panel B) Total RNA (10 f ig)  was electro- 
phoresed in formaldehyde gels, transferred to nylon membranes, and hybridized to gene- 
specific 19-mer oligonucleotide probes (see MATERIALS A N D  METHODS). The autoradiographs 
in (A) and (B) were exposed for 3 days and 6 h, respectively. p'"", pmdJ"'. 
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p- and y-globin genes are expressed during development in a manner similar to that 
of their murine homologs, pmaJor and ph', respectively."" However, our results, using 
the 40-kb Kgn I fragment from the human P-globin gene locus, demonstrate a 
pattern of expression of the normal human and p-globin genes that is different 
from that of their murine homologs. Although the endogenous mouse adult pmnJur- 
globin gene was fully active in both fetal liver and adult erythroid cells, the human 
P-globin gene was virtually inactive in fetal liver. Furthermore, whereas endogenous 
mouse embryonic Ph'-globin mRNA was virtually absent in fetal liver RNA, human 
"y-globin mRNA was readily detectable in the same R N A  sample. It is noteworthy 
that the patterns of developmental stage-specific expression of the human p- and 
*y-globin genes in the 40-kb Kpn I fragment of our transgenic mice are similar to 
those observed during human development. The differences in the developmental 
pattern of expression between individual cloned human genes and those in the 40-kb 
Kpn I fragment of the P-globin gene cluster suggest that the overall organization of 
the globin gene cluster, including the presence of intergenic DNA, is an important 
determinant for the stage-specific expression of the human @-like globin genes 
during development. 
10 kb 




FIGURE 6. Diagram showing the relationship between the p-globin gene enhancer (E) and the 
"y-globin gene promoter in the tandemly repeated 40-kb transgene. 
SIJMMARY 
We have introduced into the mouse germ line the 40-kilobase (kb) Kpn I 
fragment containing the P-globin gene cluster from an individual with a non-deletion 
form of hereditary persistence of fetal hemoglobin (HPFH) believed to be due to a 
point mutation at  position -202 of the 'y-globin gene. The "y-globin gene, as well as 
the P-globin gene, was expressed in adult erythroid tissues of the resulting transgenic 
mice. The level of expression of the "y-globin gene was about 20% of that of the 
P-globin gene. Others have previously shown that cloned individual normal human 
P- and y-globin genes containing a limited amount of 5'- and 3'-flanking DNA are 
expressed in a manner similar to that of their corresponding murine homologs during 
development in transgenic mice. In contrast, we have observed that the pattern of 
expression of thc normal (non-mutated) "y- and P-globin genes in the 40-kb insert 
was different from that of their corresponding murine homologs. The p-globin gene 
remained inactive at the fetal stage, whereas the normal "y-globin gene was 
expressed beyond the embryonic (yolk. sac) stage into the fetal stage of development 
and then became inactive in adult erythroid cells. The pattern of expression of the 
human globin transgenes during mouse development resembles that observed during 
human development. These results suggest that the gross organization of the human 
P-like globin gene cluster is importarit for stage-specific expression of each human 
globin gene during development. 
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